Thermal Stability of High Power 26650-Type Cylindrical Na-Ion Batteries

来源 :中国物理快报(英文版) | 被引量 : 0次 | 上传用户:a13315157220
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
As a new electrochemical power system,safety (especially thermal safety) of Na-ion batteries (NIBs) is the key towards large-scale industrialization and market application.Thus,research on the thermal stability of NIBs is helpful to evaluate the safety properties and to provide effective strategies to prevent the occurrence of battery safety failure.Thermal stability of the high-power 26650 cylindrical NIBs using Cu-based layered oxide cathode and hard carbon anode is studied.The high power NIBs can achieve fast charge and discharge at 5-10 C rate and maintain 80% capacity after 4729 cycles at 2 C/2 C rate,where the unit C denotes a measure of the rate at which a battery is charge-discharged relative to its maximum capacity.The results of accelerating rate calorimeter and differential scanning calorimetry (ARC-DSC) test results show that NIBs have a higher initial decomposition temperature (≥110 ℃) and a lower maximum thermal runaway temperature (≤350 ℃) than those of Li-ion batteries (LIBs),exhibiting a favorable thermal stability.It should be noted that the heat generation of cathode accounts for a large proportion of the total heat generation while the thermal stability of the anode determines the initial thermal runaway temperature,which is similar to LIBs.Finally,the whole temperature characteristics of the NIBs in the range of-60 ℃-1000 ℃ are summarized,which provide guidance for the safety design and applications of NIBs.
其他文献
1.ObjectivernLop Nur is currently one of the world 's largest playa and located in the easternmost of the Tarim Basin,northwestern China.It developed unique gia
期刊
We propose a new method to construct low-dimensional quantum devices consisting of the magnetic topological insulators.Unlike previous systems based on locally
期刊
基于生物药剂学分类系统(BCS)的生物等效性豁免旨在减少对体内生物等效性研究的需求,即可以提供一种体内生物等效性的替代方法。基于BCS分类的生物等效性豁免需提供药物的溶解性、渗透性和体外溶出数据。主要论述药物溶解性、渗透性和体外溶出度测定的方法,希望建立药物相关特性的标准化、规范化测定流程,以保证企业在申报生物等效性豁免时,所提供的数据是准确、可靠的。
在仿制药研究过程中通过体外评价方法替代体内生物等效性研究可以减少临床资源消耗,加快药品上市进度,这是基于生物药剂学分类系统(BCS)的生物等效性豁免的主要原因。随着我国仿制药的快速发展,企业基于BCS的生物豁免申请需求越来越迫切,当药物制剂为具有全身作用的普通口服制剂,且药物活性成分符合溶解性和渗透性(BCS I和III类)标准,受试制剂剂型和规格与参比制剂相同,可适用基于BCS的生物等效性豁免。对国内外的基于BCS分类的生物豁免研究进展和法规进行综述,并对具体操作及申报要求提出一些思考。
Near-bottom observation data from the manned deep submersible Jiaolong with high-precision underwater positioning data from Weijia Guyot,Magellan Seamounts in the Western Pacific Ocean are reported.Three substrate types were identified:Sediment,ferromanga
Topological superconductors (TSCs) have been widely investigated in recent years due to their novel physics and ability to host Majorana fermions (MFs) which ar
期刊
We introduce a generalized Rashba coupling approximation to analytically solve confined two-dimensional electron systems with both the Rashba and Dresselhaus sp
期刊
只有临床试验充分反映最有可能使用药物的人群,才能获得药物上市后用药人群不同亚群的临床安全有效使用的准确信息。然而目前许多临床试验的某些人群的代表性仍然不足。为改变这种状态,美国食品药品监督管理局(FDA)于2020年11月发布了“提高临床试验人群的多样性——合格标准、纳入实践和试验设计供企业用指导原则”。该指导原则推荐了许多方法,扩大临床试验参与者的合格标准、避免不必要地排除,促进临床试验人群的多样性,内容丰富、详实、切实可行。详细介绍该指导原则,期待对我国积极开展这方面的工作有促进作用。
目的研究佐匹克隆的生物药剂学分类系统(BCS),并对原研和3家仿制企业原料的关键理化性质进行对比评价,为佐匹克隆片剂的一致性评价提供依据。方法检测pH 6.8和pH 7.4的磷酸盐缓冲液中佐匹克隆的固有溶出速率;分别采用差示扫描量热法(DSC)和X射线粉末衍射法对佐匹克隆的晶型进行考察;采用高效液相色谱(HPLC)法测定佐匹克隆不同pH介质中的平衡溶解度及表观油水分配系数;分别采用平行人工膜渗透性模型(PAMPA)和Caco-2细胞模型,考察佐匹克隆的有效渗透性。对佐匹克隆的BCS进行初步判定,并考察原研
During the Late Neoproterozoic and Early Cambrian,a series of paleogeographic and paleoecological events occurred associated with deglaciations and the evolution of life.The appearance of fossils representing diverse phyla,novel body plans and complex eco